The annual grants of the Cancer Foundation and the Cancer Society of Finland totalled 5,9 million and were awarded to 152 research projects in Finland.
Researchers at the University of Tampere received a total of EUR 594,000 euro for eight projects.
The largest grant of EUR 225,000 was awarded to Professor Tapio Visakorpi for research on the precision treatment of prostate cancer.
Professor Olli Silvennoinen and his research group received a three-year grant of EUR 150,000 for the project “Signalling in hematological malignancies and cancer: Targeting the “undruggable””.
Professor Johanna Mäenpää received EUR 50,000 for research on the mechanisms of drug resistance in the treatment of ovarian cancer.
Professor Matti Lehtinen and his research group received EUR 50,000 for research on a vaccine for the human papilloma virus.
Adjunct Professor Olli Lohi and his research group were granted EUR 60,000 for research on new medical therapies in acute leukaemia.
Professor Terho Lehtimäki and his research group were granted EUR 50,000 for research on the mechanisms of atorvastatin in prostate cancer.
Master of Science Zuzet Martinez Cordova received EUR 4,000 for her doctoral research on the role of proprotein convertase FURIN in cancer immunity.
Master of Arts Susanna Teppo received EUR 5,000 for her doctoral research on the transcriptional profiling of juvenile t(1;19)-leukaemia and new medical treatment options.